Pharmacy Medical News about Migraine Disorders Central Nervous System Stimulants

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Headache: Efficacy of Stimulants in Migraineurs with Comorbidities
Practical Pain Management, 09/28/09

Robbins L et al. – Amphetamines have been shown to possess intrinsic analgesic properties, primarily through brain catecholamine activity. They also intensify the analgesic effects of certain opioids. When prescribed for headache patients, stimulants may be beneficial for various comorbidities such as attention deficit hyperactivity disorder (ADHD), depression and fatigue. In addition, stimulants do not cause the weight gain that is seen with a number of other current headache preventives. This article reviews the authors' experience with stimulants in chronic migraine patients over a period of six years.

<< Previous
The current state of the art of chemotherapy of penile cancer

Next >>
Is liraglutide or exenatide better in type 2 diabetes?

Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system
Brain, 11/03/09 Relevance Score: 88%

Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
Thrombosis Research, 10/26/09 Relevance Score: 88%

Psychosis From Anticholinergic Medications Administered at a Smoking Cessation Clinic
Journal of Pharmacy Practice, 10/23/09 Relevance Score: 88%

Migraine presenting as chronic facial pain
Acta Neurologica Belgica, 10/16/09 Relevance Score: 88%

Clinical implications of neuropsychiatric systemic lupus erythematosus
Advances in Psychiatric Treatment, 11/04/09 Relevance Score: 87%